バクテリオファージ市場：タイプ、製品、形態、送達モード、用途、エンドユーザー別-2025-2030年予測

バクテリオファージ市場は、2023年に4,774万米ドルと評価され、2024年には5,015万米ドルに達すると予測され、CAGR 5.26%で成長し、2030年には6,835万米ドルに達すると予測されています。

特定の細菌に感染して溶菌するウイルスであるバクテリオファージは、抗生物質耐性感染症対策やマイクロバイオーム制御の精密ツールとしての可能性が注目されています。代替抗菌治療へのニーズが高まる中、抗生物質耐性の危機に対処する必要性と個別化医療への関心の高まりに後押しされ、バクテリオファージ市場は拡大する見通しです。アプリケーションはヘルスケア、農業、食品安全など多岐にわたり、バクテリオファージは農作物保護の強化や食品の腐敗防止に使用されています。最終用途の範囲は、主に病院、診療所、研究機関、農業部門です。主な成長要因としては、ファージ療法に対する認知度の向上、遺伝子工学の進歩によるファージ・ソリューションのオーダーメイド化、市場参入を容易にする各国の規制支援などが挙げられます。しかし、市場開拓には高い開発コスト、複雑な承認規制の枠組み、ヘルスケア専門家の認知度の低さなどの制約があります。さらに、ファージの特異性は利点ではあるが、細菌株ごとに特化したソリューションが必要となるため、課題ともなりうる。最新の潜在的なビジネスチャンスは、合成ファージと併用療法の開発、ファージベースの生物農薬のための農業部門とのパートナーシップの構築、より広範な感染性病原体をカバーするためのファージライブラリーの拡張にあります。推奨事項としては、医療関係者に受け入れられるようにターゲットを絞ったマーケティング・キャンペーンに投資すること、生産を効率化するためにバイオテクノロジー企業との提携を促進すること、アプリケーション・ポートフォリオを多様化するために複数の地域との提携を追求することなどが挙げられます。課題はあるもの、合成生物学の進歩や送達システムの革新といった分野は、差別化のための絶好の機会を提供しています。ファージと宿主の相互作用の調査やファージの安定性の最適化により、商業的な実現可能性がさらに高まる可能性があります。地域の市場変化や規制状況を理解することは、地域のビジネスチャンスを生かす上で極めて重要であり、一方、送達メカニズムやファージ製剤における継続的な技術革新は、この急成長市場におけるビジネス成長の最良の道を提供します。

市場力学：急速に進化するバクテリオファージ市場の主要市場インサイトを公開

バクテリオファージ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 抗生物質耐性細菌感染症の蔓延がバクテリオファージ療法の需要を牽引
  • ヘルスケアにおけるバクテリオファージ応用のための研究開発投資の増加
  • バクテリオファージが抗生物質に代わる有効な選択肢であることの認識と受容の高まり
  • 食品安全および農業生産性向上におけるバクテリオファージ応用の拡大
• 市場抑制要因
  • バクテリオファージ療法に対する医療従事者や患者からの認知度や受容度の低さ
  • バクテリオファージ治療の採用を制限する既存の抗生物質治療との高い競合
• 市場機会
  • 製薬企業との提携によるバクテリオファージ医薬品開発パイプラインの促進
  • バクテリオファージを獣医学に応用し、動物の健康と食糧生産を向上させる
  • バクテリオファージ療法と従来の抗生物質との併用による相乗効果
• 市場の課題
  • バクテリオファージ療法の標準化されたプロトコールがないため、臨床への導入と一貫性が阻害されています。
  • バクテリオファージの特異性が高く、異なる細菌株に対して個別に開発する必要があります。

ポーターの5つの力：バクテリオファージ市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バクテリオファージ市場における外部からの影響の把握

外部マクロ環境要因は、バクテリオファージ市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析バクテリオファージ市場における競合情勢の把握

バクテリオファージ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスバクテリオファージ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バクテリオファージ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨バクテリオファージ市場における成功への道筋を描く

バクテリオファージ市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 抗生物質耐性菌感染症の増加により、バクテリオファージ治療の需要が高まっている
    • ヘルスケアにおけるバクテリオファージアプリケーションの研究開発への投資増加
    • 抗生物質に代わる実行可能な代替薬としてのバクテリオファージに対する一般の認識と受容が高まっている
    • 食品安全と農業生産性向上におけるバクテリオファージの適用拡大
  • 抑制要因
    • ヘルスケア従事者と患者の間でのバクテリオファージ療法の認知度と受容度は限られている
    • 既存の抗生物質治療との激しい競合により、バクテリオファージ療法の採用が制限されている
  • 機会
    • 製薬企業と連携し、医薬品開発パイプラインの加速を目指す
    • 動物の健康と食糧生産を改善するために獣医学におけるバクテリオファージの使用を実施する
    • 相乗効果を得るために従来の抗生物質と組み合わせてバクテリオファージ療法を活用する
  • 課題
    • バクテリオファージ療法の標準化されたプロトコルの欠如が臨床での採用と一貫性を妨げている
    • 異なる細菌株ごとに個別の開発を必要とするバクテリオファージの高い特異性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTLE分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 バクテリオファージ市場：タイプ別

• 溶原性
• 溶解性

第7章 バクテリオファージ市場：製品別

• ファージ診断製品
• ファージ調査ツール
• ファージ療法製品

第8章 バクテリオファージ市場：形態別

• 液体
• 固体

第9章 バクテリオファージ市場配送方法別

• 注射可能
• オーラル
• 話題

第10章 バクテリオファージ市場：用途別

• 農業
• 診断
• 治療的
  • 人間の治療
  • 獣医治療

第11章 バクテリオファージ市場：エンドユーザー別

• 病院と診療所
• 製薬会社
• 調査機関

第12章 南北アメリカのバクテリオファージ市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋地域のバクテリオファージ市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカのバクテリオファージ市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. Adaptive Phage Therapeutics
• 2. AmpliPhi Biosciences Corporation
• 3. Armata Pharmaceuticals Inc.
• 4. ContraFect Corporation
• 5. CYTOO S.A.
• 6. Eligo Bioscience
• 7. EnBiotix Inc.
• 8. Fixed-Phage Limited
• 9. Intralytix Inc.
• 10. iNtRON Biotechnology
• 11. Locus Biosciences Inc.
• 12. Micreos BV
• 13. Optipharm Co. Ltd.
• 14. Phage International Inc.
• 15. Phagelux Inc.
• 16. Phagomed Biopharma GmbH
• 17. Pherecydes Pharma
• 18. Phico Therapeutics Ltd.
• 19. Sexton Biotechnologies
• 20. TechnoPhage SA

LIST OF FIGURES

• FIGURE 1. BACTERIOPHAGE MARKET RESEARCH PROCESS
• FIGURE 2. BACTERIOPHAGE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BACTERIOPHAGE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BACTERIOPHAGE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BACTERIOPHAGE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BACTERIOPHAGE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. AMERICAS BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 21. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. BACTERIOPHAGE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 27. BACTERIOPHAGE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BACTERIOPHAGE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BACTERIOPHAGE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BACTERIOPHAGE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BACTERIOPHAGE MARKET DYNAMICS
• TABLE 7. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BACTERIOPHAGE MARKET SIZE, BY LYTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PHAGE DIAGNOSTIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PHAGE RESEARCH TOOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PHAGE THERAPY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BACTERIOPHAGE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BACTERIOPHAGE MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BACTERIOPHAGE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BACTERIOPHAGE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BACTERIOPHAGE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BACTERIOPHAGE MARKET SIZE, BY HUMAN THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BACTERIOPHAGE MARKET SIZE, BY VETERINARY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BACTERIOPHAGE MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL BACTERIOPHAGE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. CANADA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. CANADA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. CANADA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 57. CANADA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 58. CANADA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. CANADA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 60. CANADA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. CHINA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. CHINA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. CHINA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 94. CHINA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 95. CHINA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. CHINA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 97. CHINA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. INDIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. INDIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. INDIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 101. INDIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 102. INDIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. INDIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 104. INDIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. INDONESIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. INDONESIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. INDONESIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 108. INDONESIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. JAPAN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. JAPAN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. JAPAN BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 115. JAPAN BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 122. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 129. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 136. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 143. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. TAIWAN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. TAIWAN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. TAIWAN BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 150. TAIWAN BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. THAILAND BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. THAILAND BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. THAILAND BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 157. THAILAND BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. VIETNAM BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. VIETNAM BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. VIETNAM BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 164. VIETNAM BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 176. DENMARK BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. DENMARK BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. DENMARK BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 179. DENMARK BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. EGYPT BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. EGYPT BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. EGYPT BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 186. EGYPT BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. FINLAND BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. FINLAND BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. FINLAND BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 193. FINLAND BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. FRANCE BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 198. FRANCE BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199. FRANCE BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 200. FRANCE BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 204. GERMANY BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 205. GERMANY BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 206. GERMANY BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 207. GERMANY BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. ISRAEL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 212. ISRAEL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 213. ISRAEL BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 214. ISRAEL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 218. ITALY BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 219. ITALY BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 220. ITALY BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 221. ITALY BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 222. ITALY BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. ITALY BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 224. ITALY BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 226. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 227. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 228. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 232. NIGERIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 233. NIGERIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 234. NIGERIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 235. NIGERIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 239. NORWAY BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 240. NORWAY BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 241. NORWAY BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 242. NORWAY BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 246. POLAND BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 247. POLAND BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 248. POLAND BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 249. POLAND BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 250. POLAND BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 251. POLAND BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 252. POLAND BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 253. QATAR BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 254. QATAR BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 255. QATAR BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 256. QATAR BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 257. QATAR BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 258. QATAR BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 259. QATAR BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 260. RUSSIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 261. RUSSIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 262. RUSSIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 263. RUSSIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 267. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 268. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 269. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 270. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 274. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 275. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 276. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 277. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 281. SPAIN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 282. SPAIN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 283. SPAIN BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 284. SPAIN BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 285. SPAIN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 288. SWEDEN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 289. SWEDEN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 290. SWEDEN BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 291. SWEDEN BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 292. SWEDEN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 295. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 296. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 297. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 298. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 299. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 302. TURKEY BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 303. TURKEY BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 304. TURKEY BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 305. TURKEY BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 306. TURKEY BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 309. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 310. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 311. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 312. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 313. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 314. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 315. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 316. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 317. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 318. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 319. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 320. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 321. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 322. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 323. BACTERIOPHAGE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 324. BACTERIOPHAGE MARKET, FPNV POSITIONING MATRIX, 2023

The Bacteriophage Market was valued at USD 47.74 million in 2023, expected to reach USD 50.15 million in 2024, and is projected to grow at a CAGR of 5.26%, to USD 68.35 million by 2030.

Bacteriophages, viruses that infect and lyse specific bacteria, have garnered attention for their potential in combating antibiotic-resistant infections and as precision tools in microbiome modulation. With an escalating need for alternative antibacterial treatments, the bacteriophage market is set to expand, propelled by the necessity to address antibiotic resistance crises and growing interest in personalized medicine. Applications extend across healthcare, agriculture, and food safety, where bacteriophages are used to enhance crop protection and prevent food spoilage. The end-use scope predominantly covers hospitals, clinics, research institutes, and agricultural sectors. Key growth factors include increasing awareness of phage therapy, advancements in genetic engineering which allow for tailored phage solutions, and regulatory support in several countries easing market entry. However, the market faces limitations such as high costs of development, complex regulatory frameworks for approval, and limited awareness among healthcare professionals. Additionally, phages' specificity, while an advantage, can also pose a challenge as it necessitates tailored solutions for each bacterial strain. The latest potential opportunities lie in the development of synthetic phages and combination therapies, creating partnerships with agriculture sectors for phage-based biopesticides, and expanding phage libraries to cover a broader range of infectious pathogens. Recommendations include investing in targeted marketing campaigns to increase acceptance among medical professionals, fostering collaborations with biotechnology firms to streamline production, and pursuing multi-regional partnerships to diversify application portfolios. Despite challenges, areas like synthetic biology advancements and delivery system innovations present ripe opportunities for differentiation. Research into phage-host interactions and optimizing phage stability could further enhance commercial viability. Understanding regional market variations and regulatory landscapes will be crucial for capitalizing on local opportunities, while continuous innovation in delivery mechanisms and phage formulations offer the best avenues for business growth in this burgeoning market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bacteriophage Market

The Bacteriophage Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of antibiotic-resistant bacterial infections driving demand for bacteriophage therapy
  • Rising investments in research and development for bacteriophage applications in healthcare
  • Growing public awareness and acceptance of bacteriophage as a viable alternative to antibiotics
  • Expansion of bacteriophage application in food safety and agricultural productivity enhancement
• Market Restraints
  • Limited awareness and acceptance of bacteriophage therapy among healthcare professionals and patients
  • High competition from established antibiotic treatments limiting bacteriophage therapy adoption
• Market Opportunities
  • Collaborating with pharmaceutical companies to accelerate bacteriophage drug development pipelines
  • Implementing bacteriophage use in veterinary medicine to improve animal health and food production
  • Utilizing bacteriophage therapies in combination with traditional antibiotics for synergistic effects
• Market Challenges
  • Lack of standardized protocols for bacteriophage therapy impeding clinical adoption and consistency
  • High specificity of bacteriophages requiring individualized development for different bacterial strains

Porter's Five Forces: A Strategic Tool for Navigating the Bacteriophage Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bacteriophage Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bacteriophage Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bacteriophage Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bacteriophage Market

A detailed market share analysis in the Bacteriophage Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bacteriophage Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bacteriophage Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bacteriophage Market

A strategic analysis of the Bacteriophage Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bacteriophage Market, highlighting leading vendors and their innovative profiles. These include Adaptive Phage Therapeutics, AmpliPhi Biosciences Corporation, Armata Pharmaceuticals Inc., ContraFect Corporation, CYTOO S.A., Eligo Bioscience, EnBiotix Inc., Fixed-Phage Limited, Intralytix Inc., iNtRON Biotechnology, Locus Biosciences Inc., Micreos BV, Optipharm Co. Ltd., Phage International Inc., Phagelux Inc., Phagomed Biopharma GmbH, Pherecydes Pharma, Phico Therapeutics Ltd., Sexton Biotechnologies, and TechnoPhage SA.

Market Segmentation & Coverage

This research report categorizes the Bacteriophage Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Lysogenic and Lytic.
• Based on Product, market is studied across Phage Diagnostic Products, Phage Research Tools, and Phage Therapy Products.
• Based on Form, market is studied across Liquid and Solid.
• Based on Delivery Mode, market is studied across Injectable, Oral, and Topical.
• Based on Application, market is studied across Agricultural, Diagnostic, and Therapeutic. The Therapeutic is further studied across Human Therapeutic and Veterinary Therapeutic.
• Based on End-User, market is studied across Hospitals and Clinics, Pharmaceutical Companies, and Research Institutions.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of antibiotic-resistant bacterial infections driving demand for bacteriophage therapy
    • 5.1.1.2. Rising investments in research and development for bacteriophage applications in healthcare
    • 5.1.1.3. Growing public awareness and acceptance of bacteriophage as a viable alternative to antibiotics
    • 5.1.1.4. Expansion of bacteriophage application in food safety and agricultural productivity enhancement
  • 5.1.2. Restraints
    • 5.1.2.1. Limited awareness and acceptance of bacteriophage therapy among healthcare professionals and patients
    • 5.1.2.2. High competition from established antibiotic treatments limiting bacteriophage therapy adoption
  • 5.1.3. Opportunities
    • 5.1.3.1. Collaborating with pharmaceutical companies to accelerate bacteriophage drug development pipelines
    • 5.1.3.2. Implementing bacteriophage use in veterinary medicine to improve animal health and food production
    • 5.1.3.3. Utilizing bacteriophage therapies in combination with traditional antibiotics for synergistic effects
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of standardized protocols for bacteriophage therapy impeding clinical adoption and consistency
    • 5.1.4.2. High specificity of bacteriophages requiring individualized development for different bacterial strains
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bacteriophage Market, by Type

• 6.1. Introduction
• 6.2. Lysogenic
• 6.3. Lytic

7. Bacteriophage Market, by Product

• 7.1. Introduction
• 7.2. Phage Diagnostic Products
• 7.3. Phage Research Tools
• 7.4. Phage Therapy Products

8. Bacteriophage Market, by Form

• 8.1. Introduction
• 8.2. Liquid
• 8.3. Solid

9. Bacteriophage Market, by Delivery Mode

• 9.1. Introduction
• 9.2. Injectable
• 9.3. Oral
• 9.4. Topical

10. Bacteriophage Market, by Application

• 10.1. Introduction
• 10.2. Agricultural
• 10.3. Diagnostic
• 10.4. Therapeutic
  • 10.4.1. Human Therapeutic
  • 10.4.2. Veterinary Therapeutic

11. Bacteriophage Market, by End-User

• 11.1. Introduction
• 11.2. Hospitals and Clinics
• 11.3. Pharmaceutical Companies
• 11.4. Research Institutions

12. Americas Bacteriophage Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Bacteriophage Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Bacteriophage Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Adaptive Phage Therapeutics
• 2. AmpliPhi Biosciences Corporation
• 3. Armata Pharmaceuticals Inc.
• 4. ContraFect Corporation
• 5. CYTOO S.A.
• 6. Eligo Bioscience
• 7. EnBiotix Inc.
• 8. Fixed-Phage Limited
• 9. Intralytix Inc.
• 10. iNtRON Biotechnology
• 11. Locus Biosciences Inc.
• 12. Micreos BV
• 13. Optipharm Co. Ltd.
• 14. Phage International Inc.
• 15. Phagelux Inc.
• 16. Phagomed Biopharma GmbH
• 17. Pherecydes Pharma
• 18. Phico Therapeutics Ltd.
• 19. Sexton Biotechnologies
• 20. TechnoPhage SA